We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+11.49%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
–
AUM
$2.27B
AUM Growth
-$163M
Cap. Flow
-$390M
Cap. Flow %
-17.16%
Top 10 Hldgs %
60.11%
Holding
1,283
New
44
Increased
84
Reduced
363
Closed
631

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$34.6M
2
APH icon
Amphenol
APH
+$26.5M
3
ICE icon
Intercontinental Exchange
ICE
+$18.2M
4
FAST icon
Fastenal
FAST
+$12.5M
5
TXN icon
Texas Instruments
TXN
+$12.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$68.4M
2
AMZN icon
Amazon
AMZN
+$32.5M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$25M
4
DAVA icon
Endava
DAVA
+$22.8M
5
MSFT icon
Microsoft
MSFT
+$22.7M

Sector Composition

Rank Sector Weight
1 Technology 27.54%
2 Financials 24.9%
3 Consumer Discretionary 12.74%
4 Communication Services 11.34%
5 Healthcare 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNBX
651
DELISTED
BNB PLUS CORP
BNBX
– –
0
– -$43
API
652
Agora
API
$347M
– –
-40
Closed -$1.16K
APP icon
653
Applovin
APP
$106B
– –
-50
Closed -$3.62K
APPN icon
654
Appian
APPN
$3.04B
– –
-2,500
Closed -$231K
APPS icon
655
Digital Turbine
APPS
$1.34B
– –
-350
Closed -$24.1K
AQMS icon
656
Aqua Metals
AQMS
$9.7M
– –
-50
Closed -$20.7K
AR icon
657
Antero Resources
AR
$11.8B
– –
-750
Closed -$14.1K
ARCC icon
658
Ares Capital
ARCC
$14.3B
– –
-450
Closed -$9.15K
ARCT icon
659
Arcturus Therapeutics
ARCT
$432M
– –
-73
Closed -$3.49K
ARKF icon
660
ARK Blockchain & Fintech Innovation ETF
ARKF
$816M
– –
-500
Closed -$24.7K
ARKG icon
661
ARK Genomic Revolution ETF
ARKG
$1.88B
– –
-2,508
Closed -$187K
ARKK icon
662
ARK Innovation ETF
ARKK
$6.46B
– –
-387
Closed -$42.8K
ARKW icon
663
ARK Web x.0 ETF
ARKW
$1.83B
– –
-50
Closed -$6.94K
ARLP icon
664
Alliance Resource Partners
ARLP
$3.37B
– –
-212
Closed -$2.3K
ARRY icon
665
Array Technologies
ARRY
$707M
– –
-1,708
Closed -$31.6K
ASA
666
ASA Gold and Precious Metals
ASA
$1.19B
– –
-750
Closed -$14.2K
ASAN icon
667
Asana
ASAN
$2.35B
– –
-40
Closed -$4.15K
ASML icon
668
ASML
ASML
$651B
– –
-17
Closed -$12.7K
ASTS icon
669
AST SpaceMobile
ASTS
$17.4B
– –
-450
Closed -$4.87K
ATOS icon
670
Atossa Therapeutics
ATOS
$25.7M
– –
-21
Closed -$1.04K
AU icon
671
AngloGold Ashanti
AU
$57.2B
– –
-770
Closed -$12.3K
AUTL
672
Autolus Therapeutics
AUTL
$623M
– –
-46,217
Closed -$303K
AVAL icon
673
Grupo Aval
AVAL
$6.23B
– –
-515
Closed -$2.98K
AVTX icon
674
Avalo Therapeutics
AVTX
$1.05B
– –
-3
Closed -$20.3K
AWK icon
675
American Water Works
AWK
$27.5B
– –
-250
Closed -$42.3K
25 26
27
28 29

Similar funds

AP
Advisor Partners Walnut Creek, California $1.42B AUM 3.97% 1-Year Est. Return
AWM
Altium Wealth Management Purchase, New York $1.39B AUM 12.44% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $962M AUM 8.45% 1-Year Est. Return
BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
DHFB
Dixon Hubard Feinour & Brown Roanoke, Virginia $842M AUM 2.74% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return

RBC Europe's Q4 2021 Portfolio in Review

As of Q4 2021, RBC Europe held 1,283 positions worth $2.27B, down 6.7% from $2.44B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

RBC Europe withdrew a net $390M in Q4 2021, closing 631 positions and reducing 363 holdings. Its most notable exit was Endava, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, RBC Europe opened a new position in Brown & Brown worth $2.02M.

  • RBC Europe's largest Q4 2021 buy was Brown & Brown: 28,685 shares worth $2.02M.
  • RBC Europe added most to Thermo Fisher Scientific in Q4 2021, an estimated $34.6M increase.
  • RBC Europe's biggest Q4 2021 reduction was Apple, cutting an estimated $68.4M.
  • RBC Europe fully exited Endava in Q4 2021, selling an estimated $22.8M.
  • RBC Europe's ten largest holdings make up 60% of its $2.27B portfolio in Q4 2021.
  • RBC Europe opened 44 new positions and closed 631 in Q4 2021.
  • RBC Europe's portfolio value fell 6.7% quarter-over-quarter to $2.27B.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.